privosegtor   Click here for help

GtoPdb Ligand ID: 13222

Synonyms: BN-201 | BN201 | OCS-05
Compound class: Synthetic organic
Comment: The chemical structure for privosegtor was obtained from proposed INN list 130 (Feb. 2024), in which the compound is described as a serum/ glucocorticoid-regulated kinase 2 (SGK2) activator. This is a structural match for clinical candidate OCS-05 (also known as BN201) that is being investigated as a neuroprotective therapy [2].
2D Structure
Click here for help

2D Structure

An image of the ligand's 2D structure. For small molecules with SMILES these are drawn using the NCI/CADD Chemical Identifier Resolver. Click on the image to access the chemical structure search tool with the ligand pre-loaded in the structure editor. For other types of ligands, e.g. longer nucleotides and peptides, a manually drawn representation of the molecule may be provided.

✖
Click here for structure editor
Physico-chemical Properties
Click here for help

Physico-chemical Properties

Calculated molecular properties are available for small molecules and natural products (not peptides). Properties were generated using the CDK toolkit. All properties were selected to enable the prediction of the Lipinski Rule-of-Five profile or ‘druglikeness’ for each ligand. For more info on each category see the help pages.

✖
Hydrogen bond acceptors 9
Hydrogen bond donors 2
Rotatable bonds 17
Topological polar surface area 116.05
Molecular weight 491.6
XLogP -0.89
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help

SMILES / InChI / InChIKey

SMILES (Simplified Molecular Input Line Entry Specification) A specification for unambiguously describing the structure of chemical molecules using short ASCII strings. Canonical SMILES specify a unique representation of the 2D structure without chiral or isotopic specifications. Isomeric SMILES include chiral specification and isotopes.

Standard InChI (IUPAC International Chemical Identifier) and InChIKey InChI is a non-proprietary, standard, textual identifier for chemical substances designed to facilitate linking of information and database searching. An InChIKey is a simplified version of a full InChI, designed for easier web searching.

✖
Canonical SMILES CC(C)CN(CC(=O)N(CCCN1CCCC1=O)CC(=O)N)C(=O)CNCCC2=C(C=CC=C2)F
Isomeric SMILES FC1=C(C=CC=C1)CCNCC(=O)N(CC(=O)N(CC(=O)N)CCCN2C(CCC2)=O)CC(C)C
InChI InChI=1S/C25H38FN5O4/c1-19(2)16-31(24(34)15-28-11-10-20-7-3-4-8-21(20)26)18-25(35)30(17-22(27)32)14-6-13-29-12-5-9-23(29)33/h3-4,7-8,19,28H,5-6,9-18H2,1-2H3,(H2,27,32)
InChI Key ODCKWAPNRBCXHV-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
As OCS-05 this SGK2 peptidomimetic has advanced to clinical evaluation for efficacy in acute optic neuritis and multiple sclerosis [1]. OCS-05 is administered intravenously. As SN201 this agent was was granted FDA orphan designation for the treatment of optic neuritis in 2014.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT04762017 OCS-05 in Patients With Acute Optic Neuritis Phase 2 Interventional Oculis
NCT03630497 BN201 SAD MAD Study in Healthy Subjects Phase 1 Interventional Accure Therapeutics